● FDA CSAOverviewSource LibraryArticles & ClausesApplicabilityInterpretationEvidence ReadinessAI GovernanceOperational FlowActors & ServicesUpdates & Assets
Regulations/FDA CSA/Operational Flow
Operational Flow · FDA CSA

Operational Flow for FDA CSA.

This page describes the operating route from source text to practical use. It maps handoffs, gates, failure points, and review moments so the work can move without losing traceability.

Source basis: Computer Software Assurance for Production and Quality System SoftwareUse: evidence-readinessBoundary: not legal advice
FDA CSA TRACE FDA CSA FINAL GUIDQMSR TERMINOLOGYPRODUCTION SOFTWQUALITY MANAGEME
/ Operational route

The flow moves from source to reviewable work.

FDA CSA
Flow

Recommended operating sequence.

List software · Define intended use · Assess patient/product/process risk · Choose assurance method · Capture objective evidence · Approve and change-control · Periodically review

07
/ Failure points

Where teams usually lose traceability.

audit watch
Risk 01

Source skipped

Using a blog summary instead of the official source creates weak claims.

Risk 02

Role unclear

Provider, deployer, sponsor, manufacturer, vendor, or owner responsibilities blur.

Risk 03

Evidence not owned

A document exists but nobody owns review, update, or closure.

Risk 04

Change not logged

Model, system, SOP, source, or guidance changes do not reach the evidence file.

Source anchors

Current public sources for FDA CSA.

official first

These links are the public source anchors for this workspace. Interpretation, checklists, and future assets should point back here before being reused outside iFeed.

Official FDA guidance

FDA CSA guidance

2026-02 · Current final guidance on computer software assurance for production and quality management system software; it supersedes the September 2025 final guidance.

open
Official FDA PDF

FDA CSA guidance PDF

2026-02 · Guidance history notes February 2026 revisions to align terminology with QMSR amendments to Part 820.

open